GLAUCOMA TECH
nlightenment
G Tech Takes on
laucoma has long been a formidable challenge for ophthalmologists and patients alike. With over 80 million people affected globally, the need for innovative solutions to diagnose, manage and treat this silent thief of sight has never been more urgent.
Glaucoma
A new wave of technological innovation brings new hope to the fight against glaucoma by Hazlin Hassan
With millions at risk of irreversible blindness, the fight against glaucoma is more urgent than ever. Luckily, technology is stepping up with some seriously innovative solutions. Think AI that sees what doctors might miss, VR that makes eye exams a breeze, and drug delivery that frees patients from daily drops.
Fortunately, the field of ophthalmology is undergoing a technological renaissance, with cutting-edge tools and approaches transforming glaucoma care. From artificial intelligence (AI) to virtual reality (VR) and groundbreaking drug delivery systems, the future of glaucoma management is here. Let’s explore six of the most exciting innovations that are reshaping the landscape of glaucoma care today.
1
iCare DRS
AI is no longer the stuff of science fiction—it’s a reality in glaucoma care. Case in point: The iCare DRS1 (iCare Finland Oy; Vantaa, Finland) fundus camera, paired with its cloudbased ILLUME/RetCAD (Thirona Retina/iCare Finland Oy) AI software, has shown promise as a screening tool for glaucoma. “We were impressed with its ability as a screening tool,” said Dr. Jason Cheng, a glaucoma consultant at Sydney Eye Hospital. They are now planning to deploy this technology in Fiji to screen for both diabetic retinopathy and glaucoma in resource-limited settings.
“We were impressed with the iCare DRS' ability as a screening tool.” - Dr. Jason Cheng
This is a game-changer for early detection, especially in regions where access to specialized care is limited
2
RETFound
AI’s potential doesn’t stop there. Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology have developed
CAKE MAGAZINE | April 2025
33